159 related articles for article (PubMed ID: 30452438)
1. Co-expression of IL-15 enhances anti-neuroblastoma effectivity of a tyrosine hydroxylase-directed DNA vaccination in mice.
Marx M; Zumpe M; Troschke-Meurer S; Shah D; Lode HN; Siebert N
PLoS One; 2018; 13(11):e0207320. PubMed ID: 30452438
[TBL] [Abstract][Full Text] [Related]
2. Xenogeneic immunization with human tyrosine hydroxylase DNA vaccines suppresses growth of established neuroblastoma.
Huebener N; Fest S; Hilt K; Schramm A; Eggert A; Durmus T; Woehler A; Stermann A; Bleeke M; Baykan B; Weixler S; Gaedicke G; Lode HN
Mol Cancer Ther; 2009 Aug; 8(8):2392-401. PubMed ID: 19671753
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy with a posttranscriptionally modified DNA vaccine induces complete protection against metastatic neuroblastoma.
Pertl U; Wodrich H; Ruehlmann JM; Gillies SD; Lode HN; Reisfeld RA
Blood; 2003 Jan; 101(2):649-54. PubMed ID: 12393580
[TBL] [Abstract][Full Text] [Related]
4. A rationally designed tyrosine hydroxylase DNA vaccine induces specific antineuroblastoma immunity.
Huebener N; Fest S; Strandsby A; Michalsky E; Preissner R; Zeng Y; Gaedicke G; Lode HN
Mol Cancer Ther; 2008 Jul; 7(7):2241-51. PubMed ID: 18645033
[TBL] [Abstract][Full Text] [Related]
5. Multi-antigen DNA vaccine delivered by polyethylenimine and Salmonella enterica in neuroblastoma mouse model.
Stegantseva MV; Shinkevich VA; Tumar EM; Meleshko AN
Cancer Immunol Immunother; 2020 Dec; 69(12):2613-2622. PubMed ID: 32594197
[TBL] [Abstract][Full Text] [Related]
6. A minigene DNA vaccine encoding peptide epitopes derived from Galectin-1 has protective antitumoral effects in a model of neuroblastoma.
Liebscher L; Weißenborn C; Langwisch S; Gohlke BO; Preissner R; Rabinovich GA; Christiansen N; Christiansen H; Zenclussen AC; Fest S
Cancer Lett; 2021 Jul; 509():105-114. PubMed ID: 33848518
[TBL] [Abstract][Full Text] [Related]
7. DNA minigene vaccination for adjuvant neuroblastoma therapy.
Lode HN; Huebener N; Zeng Y; Fest S; Weixler S; Gaedicke G
Ann N Y Acad Sci; 2004 Dec; 1028():113-21. PubMed ID: 15650237
[TBL] [Abstract][Full Text] [Related]
8. Survivin minigene DNA vaccination is effective against neuroblastoma.
Fest S; Huebener N; Bleeke M; Durmus T; Stermann A; Woehler A; Baykan B; Zenclussen AC; Michalsky E; Jaeger IS; Preissner R; Hohn O; Weixler S; Gaedicke G; Lode HN
Int J Cancer; 2009 Jul; 125(1):104-14. PubMed ID: 19291796
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine hydroxylase-based DNA-vaccination is effective against murine neuroblastoma.
Lode HN; Pertl U; Xiang R; Gaedicke G; Reisfeld RA
Med Pediatr Oncol; 2000 Dec; 35(6):641-6. PubMed ID: 11107137
[TBL] [Abstract][Full Text] [Related]
10. Induction of protective immune responses against NXS2 neuroblastoma challenge in mice by immunotherapy with GD2 mimotope vaccine and IL-15 and IL-21 gene delivery.
Kowalczyk A; Wierzbicki A; Gil M; Bambach B; Kaneko Y; Rokita H; Repasky E; Fenstermaker R; Brecher M; Ciesielski M; Kozbor D
Cancer Immunol Immunother; 2007 Sep; 56(9):1443-58. PubMed ID: 17597331
[TBL] [Abstract][Full Text] [Related]
11. Conjugation of new DNA vaccine with polyethylenimine induces cellular immune response and tumor regression in neuroblastoma mouse model.
Stegantseva MV; Shinkevich VA; Tumar EM; Meleshko AN
Exp Oncol; 2020 Jun; 42(2):120-125. PubMed ID: 32602294
[TBL] [Abstract][Full Text] [Related]
12. Effect of HSV-IL12 Loaded Tumor Cell-Based Vaccination in a Mouse Model of High-Grade Neuroblastoma.
Bauer DF; Pereboeva L; Gillespie GY; Cloud GA; Elzafarany O; Langford C; Markert JM; Lamb LS
J Immunol Res; 2016; 2016():2568125. PubMed ID: 27610392
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy of neuroblastoma by an Interleukin-21-secreting cell vaccine involves survivin as antigen.
Croce M; Meazza R; Orengo AM; Fabbi M; Borghi M; Ribatti D; Nico B; Carlini B; Pistoia V; Corrias MV; Ferrini S
Cancer Immunol Immunother; 2008 Nov; 57(11):1625-34. PubMed ID: 18324400
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a novel human tumor antigen interleukin-13 receptor alpha2 chain.
Kawakami K; Terabe M; Kawakami M; Berzofsky JA; Puri RK
Cancer Res; 2006 Apr; 66(8):4434-42. PubMed ID: 16618770
[TBL] [Abstract][Full Text] [Related]
15. Targeting of MYCN by means of DNA vaccination is effective against neuroblastoma in mice.
Stermann A; Huebener N; Seidel D; Fest S; Eschenburg G; Stauder M; Schramm A; Eggert A; Lode HN
Cancer Immunol Immunother; 2015 Oct; 64(10):1215-27. PubMed ID: 26076666
[TBL] [Abstract][Full Text] [Related]
16. Transient depletion of CD4(+) T cells augments IL-21-based immunotherapy of disseminated neuroblastoma in syngeneic mice.
Croce M; Corrias MV; Orengo AM; Brizzolara A; Carlini B; Borghi M; Rigo V; Pistoia V; Ferrini S
Int J Cancer; 2010 Sep; 127(5):1141-50. PubMed ID: 20039320
[TBL] [Abstract][Full Text] [Related]
17. CpG oligonucleotides enhance the tumor antigen-specific immune response of a granulocyte macrophage colony-stimulating factor-based vaccine strategy in neuroblastoma.
Sandler AD; Chihara H; Kobayashi G; Zhu X; Miller MA; Scott DL; Krieg AM
Cancer Res; 2003 Jan; 63(2):394-9. PubMed ID: 12543793
[TBL] [Abstract][Full Text] [Related]
18. Discovery of YB-1 as a new immunological target in neuroblastoma by vaccination in the context of regulatory T cell blockade.
Zheng J; Jing W; Orentas RJ
Acta Biochim Biophys Sin (Shanghai); 2009 Dec; 41(12):980-90. PubMed ID: 20011972
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effect of programmed cell death protein 1 blockade and secondary lymphoid tissue chemokine in the induction of anti-tumor immunity by a therapeutic cancer vaccine.
Moeini S; Saeidi M; Fotouhi F; Mondanizadeh M; Shirian S; Mohebi A; Gorji A; Ghaemi A
Arch Virol; 2017 Feb; 162(2):333-346. PubMed ID: 27699512
[TBL] [Abstract][Full Text] [Related]
20. A transplantable TH-MYCN transgenic tumor model in C57Bl/6 mice for preclinical immunological studies in neuroblastoma.
Kroesen M; Nierkens S; Ansems M; Wassink M; Orentas RJ; Boon L; den Brok MH; Hoogerbrugge PM; Adema GJ
Int J Cancer; 2014 Mar; 134(6):1335-45. PubMed ID: 24038106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
